Abstract
The efficacy of Ga-67 SPECT imaging of CNS malignant lymphoma was investigated in 14 studies of 11 patients. As compared with planar images, the SPECT imaging improved the detectability of the focus of CNS malignant lymphoma. All untreated cases showed L/N ratios higher than 3.0. And the L/N ratios also changed according to remission or relapse of CNS malignant lymphoma.
Similar content being viewed by others
References
Edwards CL, Hayes RL. Tumor scanning with67Ga-citrate.J Nud Med 10: 103–105, 1969.
Turner DA, Fordham EW, Ali A, Slayton RE. Gallium-67 imaging in the management of Hodgkin’s disease and other malignant lymphomas.Seminars in Nuclear Medicine 8: 205–218, 1978.
Israel Ö, Front D, Lam M, Ben-Haim S, Kleinhaus U, Ben-Shachar M, et al. Gallium 67 imaging in monitoring lymphoma response to treatment.Cancer 61: 2439–2443, 1988.
Nedellec G, Lioure B, Bussy E, Carlioz R, Gaillard JF, Auzanneau G. Evaluation of residual masses after lymphoma treatment: the contribution of gallium-67 tomoscintigraphy.Nouvelle Revue Francaise d Hematologie 32: 187–190, 1990.
Harwood SJ, Carroll RG, Anderson M, Friedman BI, Zangara LM, Brunette AK, et al. SPECT gallium scanning for lymphoma and infection.Clin Nucl Med 12: 694–702, 1987:
Tumeh SS, Rosenthal DS, Kaplan WD, English RJ, Holman BL. Lymphoma: evaluation with Ga-67 SPECT.Radiology 164: 111–114, 1987.
Fukunaga M, Mukai T, Fujita T, Shigeno C, Morita R, Torizuka K. Emission computed tomography, using rotating gamma camera, of tumor image with67Ga-citrate— detection of involved lesions in malignant lymphoma.KAKU IGAKU (Jpn J Nucl Med) 18: 1343–1351, 1981.
Zidar BL, Adatepe M, Hryschko F, Hartsock RJ, Kessler L, Lyons TA. Diagnosis of non-Hodgkin’s lymphoma intracerebral mass lesions. Usefulness of Tc-99m pertechnetate and Ga-67 citrate brain scans.Clin Nucl Med 7: 497–501, 1982.
Kosuda S, Aoki S, Suzuki K, Nakamura H, Nakamura O, Shidara N. Primary malignant lymphoma of the central nervous system by Ga-67 and Tl-201 brain SPECT.Clin Nucl Med 17: 961–964, 1992.
Roman-Goldstein SM, Goldman DL, Howieson J, Belkin R, Neuwelt EA. MR of primary CNS lymphoma in immunologically normal patients.AJNR 13: 1207–1213, 1992.
Eby NL, Grufferman S, Flannelly CM, Schold SC, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US.Cancer 62: 2461–2465, 1988.
Petito CK, Cho E-S, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review.J Neuropathol Exp Neurol 45: 635–646, 1986.
Lee Y-Y, Bruner JM, Tassel PV, Libshitz HI. Primary central nervous system lymphoma: CT and pathologic correlation.AJR 147: 747–752, 1986.
Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors.Ann Nucl Med 7: 257–263, 1993.
Osborn AG.Diagnostic Neuroradiology. 1st ed. St. Louis: Mosby, 1994.
Palacios E, Gorelick PB, Gonzalez CF, Fine M. Malignant lymphoma of the nervous system.J Comput Assist Tomogr 6: 689–701, 1982.
Whelan MA, Kricheff II. Intracranial lymphoma.Semin Roentgenol 19: 91–99, 1984.
Schwaighofer BW, Hesselink JR, Press GA, Wolf RL, Healy ME, Berthoty DP. Primary intracranial CNS lymphoma: MR manifestations.AJNR 10: 725–729, 1989.
Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation.J Nucl Med 28: 47–52, 1987.
Akisada M, Miyamae T. Combination technique with67Gacitrate and99mTCO4 in the brain scintigraphy by the conventional rectilinear scanner.KAKU IGAKU (Jpn J Nucl Med) 12: 221–233, 1975.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujii, H., Kosuda, S., Suzuki, K. et al. Usefulness of Ga-67 brain SPECT in patients with CNS malignant lymphoma. Ann Nucl Med 10, 391–394 (1996). https://doi.org/10.1007/BF03164799
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164799